AC Immune Keeps Faith In Alzheimer’s Breakthrough, But Spreads Risk With Parkinson’s Bet

Broadened Pipeline And Prevention Strategy

 
• By Andrew McConaghie

Interview: The Swiss biotech has endured many Alzheimer’s failures, but has been able to broaden its portfolio and income streams while the search for a breakthrough goes on.

Alzheimer's PET scan
AC Immune is aiming to intercept Alzheimer's years before symptoms start to appear, by which time damaged caused by beta amyloid and tau is currently irreversible.

More from Business

More from Scrip